Ghosh S, Bhowmik S, Majumdar S, et al. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein [published online ahead of print, 2020 May 22]. Int J Cancer. 2020;10...
与治疗前AFP<20μg/L的患者比较,治疗前AFP>200μg/L的患者,其治疗后肿瘤复发率较高(P=0.018),见表1;而3年和5年无瘤生存率及总生存率较低(P=0.003,P<0.001),中位无瘤生存时间和中位总生存时间较短,见表2及图2。与治疗前sICAM-1<1 000 U/L的患者比较,治疗前sICAM-1>2 000 U/L的患者,其治疗...
recurred gastric cancertumor markerdiagnosisThe presence of serum markers was evaluated in 58 patients with recurrent gastric cancer. Of 32 patients with peritoneal recurrence, the percentage of patients whose serum samples were positive for AFP, CEA, CA19-9, and CA125 was 18.8, 37.5, 50, and...
Advancement in researches of typical marker of AFP for diagnosis and treatment of liver cancer 来自 Semantic Scholar 喜欢 0 阅读量: 5 作者:梁锋,施宝民 摘要: 虽然仍被认为足肝细胞癌(HCC)诊断中的经典标志物,在肝癌诊治有了长足进展的今天,甲胎蛋白(AFP)也不再是单纯的诊断指标.更不是惟一指标,它在...
[15] Feng H, Li B, Li Z, et al. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer, 2021,21(1):401. [16] 卫荣荣, 王成成, 李大江, 等. 异...
In addition, not every cancer will produce AFP, so you could still have cancer even when the AFP is normal. For these reasons, the AFP test is not used to screen the general population for cancer. AFP is not only a tumor marker. Because AFP is produced by the fetus, levels are ...
癌睾丸抗原(cancer testis antigen, CTA)基因在正常睾丸组织的生殖细胞和多种癌细胞中特异表达, 在其他正常组织中不表达或低水平表达. 自1991年鉴定出第1个癌睪丸抗原基因后陆续发现众多的此类基因, 因血-睾屏障的存在, 血液及其他体液或组织中的CTA基因表达产物可能都与肿瘤有关, 故CTA成为研究肿瘤诊断的重要靶标...
So AFP is usually considered a marker of hepatocyte precursors. AFP can be detected at abnormally high concentrations in hepatocellular carcinomas as well as in the plasma and ascitic fluid of adults with hepatoma. High AFP concentrations have been correlated with tumor cell growth, indicating that...
AFP阴性肝癌早期诊断的蛋白分子标志物
Cancer,1996:78:977-983. [4] Inagaki Y,Tang W,Makuuchi M,et al. Clinical and molecular insights into the hepatocellular carcinoma tumour marker desgammacarboxyprothrombin[J]. Liver Int,2011,31(1):22-35. [5] Lok AS,Steding RK,Everhart JE,et al. Des-gamma-carboxy prothrombin and alpha-...